Here are the top news stories from around the web from Rochester’s entrepreneurial and small business scene.
- Noseworthy: Mayo Clinic on Schedule to Meet DMC Developmental Targets- The Med City Beat. The Mayo Clinic CEO announced that the company is on track to deliver their DMC target funds. Over the next two decades, Mayo Clinic will invest $3.5B toward DMC projects. DMC is on track to receive $200M in private investment by the end of the year.
- Rochester Airport Keeps International Flights with $7.3M Upgrade- StarTribune. The Rochester International Airport faced a potential downgrade to municipal airport status when U.S. Customs and Border Protection found the airport’s customs facility to be outdated. The airport recently scored $7.3M in a U.S. Department of Transportation grant to upgrade the customs facility. Maintaining status as an international airport is essential to support the DMC initiative and the future of international business in Rochester.
- Claremont, MN Awarded a $500,000 CEDA Authored Business Development Public Infrastructure Grant- Community and Economic Development Associates. Claremont recently received a $500K grant for street improvements to aid in a $146M expansion of Al-Corn Clean Fuel, a farmer-owned ethanol production co-op. Three hundred construction jobs are expected to be generated for the buildout.
- Winners of the 2016 Manufacturing Awards by Minnesota Business Magazine- Minnesota Business Magazine. This week, Minnesota Business Magazine honored top manufacturers in the state with their 2015 Manufacturing Awards. Manufacturing contributes $37B to the state economy. Blooming Prairie based Minimizer was a finalist in the mid-sized company category this year. Minimizer is a leader in poly semi-truck fender manufacture.
- OneOme Lands $5.25 Million in Financing Round- Twin Cities Business. The life science startup OneOme is backed by Mayo Clinic and Invenshure, a Minneapolis incubator and venture investor. OneOme uses DNA analysis and their software product, RightMed, to minimize adverse drug reactions in patients. OneOme currently has twenty-five employees.